DE3486441D1 - 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen - Google Patents

3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen

Info

Publication number
DE3486441D1
DE3486441D1 DE3486441T DE3486441T DE3486441D1 DE 3486441 D1 DE3486441 D1 DE 3486441D1 DE 3486441 T DE3486441 T DE 3486441T DE 3486441 T DE3486441 T DE 3486441T DE 3486441 D1 DE3486441 D1 DE 3486441D1
Authority
DE
Germany
Prior art keywords
hydroxypyrid
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3486441T
Other languages
English (en)
Other versions
DE3486441T2 (de
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Technology Group Ltd filed Critical British Technology Group Ltd
Application granted granted Critical
Publication of DE3486441D1 publication Critical patent/DE3486441D1/de
Publication of DE3486441T2 publication Critical patent/DE3486441T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • External Artificial Organs (AREA)
DE3486441T 1983-03-24 1984-03-20 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen Expired - Lifetime DE3486441T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838308054A GB8308054D0 (en) 1983-03-24 1983-03-24 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE3486441D1 true DE3486441D1 (de) 1996-12-19
DE3486441T2 DE3486441T2 (de) 1997-05-07

Family

ID=10540098

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8484301881T Expired - Lifetime DE3483973D1 (de) 1983-03-24 1984-03-20 Hydroxypyridone und ihre pharmazeutischen zusammensetzungen.
DE3486441T Expired - Lifetime DE3486441T2 (de) 1983-03-24 1984-03-20 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8484301881T Expired - Lifetime DE3483973D1 (de) 1983-03-24 1984-03-20 Hydroxypyridone und ihre pharmazeutischen zusammensetzungen.

Country Status (9)

Country Link
US (2) US4585780A (de)
EP (1) EP0120669B1 (de)
JP (2) JPH0672097B2 (de)
CY (1) CY1510A (de)
DE (2) DE3483973D1 (de)
GB (2) GB8308054D0 (de)
GR (1) GR81911B (de)
HK (1) HK37590A (de)
SG (1) SG71089G (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
WO1989009211A1 (en) * 1988-03-31 1989-10-05 The Royal Free Hospital School Of Medicine Process for producing pyrid-4-ones
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
GB9002061D0 (en) * 1990-01-30 1990-03-28 Bannister Joseph V Iron assay
GB9100465D0 (en) * 1991-01-09 1991-02-20 Hider Robert C Pharmaceutical compositions
US5403862A (en) * 1992-01-17 1995-04-04 University Of Utah Research Foundation Method for oral decorporation of metals
US5494935A (en) * 1992-01-17 1996-02-27 University Of Utah Research Foundation Methods for oral decorporation of metals
GB9209078D0 (en) * 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) * 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
US5849587A (en) * 1995-06-09 1998-12-15 Cornell Research Foundation, Inc. Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
AU6010696A (en) 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
PT768302E (pt) * 1995-09-29 2005-11-30 Novartis Ag Novas hidroxipiridinonas
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US5882799A (en) * 1996-12-16 1999-03-16 Vernay Laboratories, Inc. Polymeric coupling agents for the adhesion of macromolecular materials and metal substrates
US6294152B1 (en) * 1999-01-11 2001-09-25 The University Of Toledo Iron(III) complexes as contrast agents for image enhancement in magnetic resonance imaging
US20030024913A1 (en) * 2002-04-15 2003-02-06 Downes Joseph P. Laser scanning method and system for marking articles such as printed circuit boards, integrated circuits and the like
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
US7135196B2 (en) * 2000-09-19 2006-11-14 Vitra Pharmaceuticals Limited Iron compositions
US7160482B2 (en) * 2000-12-22 2007-01-09 Imec Vzw Composition comprising an oxidizing and complexing compound
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
EP1578999B1 (de) 2002-10-30 2013-01-16 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Verfahren zur messung von nichttransferringebundenem eisen
AU2004285450B2 (en) 2003-10-20 2010-01-14 Gregory K. Frykman Zeolite molecular sieves for the removal of toxins
NZ529657A (en) 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones
WO2006028523A2 (en) * 2004-04-29 2006-03-16 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
WO2005110399A2 (en) * 2004-04-29 2005-11-24 The Regents Of The University Of California Zinc-binding groups for metalloprotein inhibitors
UY30986A1 (es) 2007-03-28 2008-09-02 Apotex Technologies Inc Derivados fluorinados de deferiprona
GB0803019D0 (en) * 2008-02-19 2008-03-26 Btg Int Ltd Fluorinated compounds
NZ588602A (en) 2008-04-25 2012-08-31 Apotex Technologies Inc Liquid formulation for deferiprone with palatable taste
DK2448922T3 (da) * 2009-07-03 2014-11-10 Apotex Technologies Inc Fluorinerede derivater af 3-hydroxypyridin-4-oner
GB201007209D0 (en) 2010-04-29 2010-06-16 King S College London Compound
CN102190644B (zh) * 2011-03-31 2012-11-21 浙江大学 手性3-羟基吡啶-4-酮类衍生物及其合成和用途
WO2012137202A1 (en) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
US20180338897A1 (en) * 2017-05-24 2018-11-29 New York University Oral compositions for reducing dental stains

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016372A (en) * 1956-12-13 1962-01-09 Searle & Co Glycosides of the pyridone series
CH449011A (de) * 1965-04-29 1967-12-31 Geigy Ag J R Verfahren zur Herstellung von 2,3-Pyridindiol
AR207322A1 (es) * 1972-12-18 1976-09-30 Merck & Co Inc Procedimiento para preparar complejos de 4,4'-dinitrocarbanilidas con derivados de piridonas 2-y 4-substituidas pirimidin-2-y-6-/nas y tetrahidroquinolonas utiles para la prevencion y tratamiento da la coccidiosis
US3847927A (en) * 1972-12-20 1974-11-12 Dow Chemical Co Sulfur-containing hydroxypyridones
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
JPS5953261B2 (ja) * 1973-08-03 1984-12-24 明治製菓株式会社 ２（１ｈ）−ピリドン誘導体の製造法
IE40057B1 (en) * 1973-11-07 1979-02-28 Richardson Merrell Inc 4-oxo-1-pyridinyl penicillin and cephalosporin derivatives
GB1591642A (en) * 1977-03-03 1981-06-24 Ciba Geigy Ag Hydroxypyridone dyestuffs
US4131131A (en) * 1977-06-22 1978-12-26 Dayco Corporation Valve construction
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
DK157856C (da) * 1982-03-24 1990-07-30 Nat Res Dev Analogifremgangsmaade til fremstilling af et 3:1 hydroxypyridon:jern (iii)-kompleks
GR78491B (de) * 1982-03-24 1984-09-27 Nat Res Dev
JPS59118792A (ja) * 1982-12-24 1984-07-09 Kyowa Hakko Kogyo Co Ltd セフエム化合物
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8325494D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions

Also Published As

Publication number Publication date
US4585780A (en) 1986-04-29
CY1510A (en) 1990-08-03
GB8308054D0 (en) 1983-05-05
EP0120669A3 (en) 1985-01-23
DE3486441T2 (de) 1997-05-07
JPH0680637A (ja) 1994-03-22
USRE35948E (en) 1998-11-03
EP0120669B1 (de) 1991-01-23
GB2136807A (en) 1984-09-26
SG71089G (en) 1990-03-02
HK37590A (en) 1990-05-25
JPH0672097B2 (ja) 1994-09-14
GB8407181D0 (en) 1984-04-26
DE3483973D1 (de) 1991-02-28
GB2136807B (en) 1987-04-23
GR81911B (de) 1984-12-12
JPS59205361A (ja) 1984-11-20
EP0120669A2 (de) 1984-10-03
JPH0764815B2 (ja) 1995-07-12

Similar Documents

Publication Publication Date Title
DE3486441T2 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
BR1100036A (pt) Composto e composição farmacêutica
SE8801813L (sv) Pharmaceutical composition
DE10199066I1 (de) Pharmazeutische Zusammensetzung
KR890701101A (ko) 제약학적 조성물
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK481989D0 (da) Farmaceutiske formuleringer
FR2636532B1 (fr) Compositions pharmaceutiques
DK237884D0 (da) Farmaceutisk praeparat
DE3486255D1 (de) Pharmazeutische Zusammensetzungen.
DE3483133D1 (de) Pharmazeutische zusammensetzungen.
DE3484098D1 (de) Pharmazeutische zusammensetzungen.
NZ209064A (en) N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
IL72515A0 (en) Coumarin deerivatives and pharmaceutical compositions containing the same
DK58983D0 (da) Farmaceutisk praeparat
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
IT1177580B (it) Composizione farmaceutica contenente rifampicina e procedimento per prepararla
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
BR8905444A (pt) Composicoes e aplicacao
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
PH19575A (en) Cephalosporing derivatives and pharmaceutical compositions thereof
MX11584A (es) Composiciones farmaceuticas
IT1216814B (it) Composizioni farmaceutiche

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BTG INTERNATIONAL LTD., LONDON, GB